Zimbabwe Issues Recall for Azithromycin Batch Due to Quality Issues

The Medicines Control Authority of Zimbabwe (MCAZ) has initiated a Class II recall for a specific batch of Azithromycin 500mg USP Tablets. This action, extending to the retail level, was prompted by the manufacturer, Indoco Remedies Limited, reporting an out-of-specification result during dissolution testing in a stability study. The recall addresses potential quality concerns for this commonly used antibiotic.